Navigation Links
Bioglue in Medical News

CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology

...ich BioGlue((R)) Surgical Adhesive was developed. bioglue is approved by the U.S. Food and Drug Administrati...staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...atients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and ap...

CryoLife Reports Record Quarterly Revenues of $28.2 Million

...t during the second quarter of 2008, which reduced bioglue revenues by $331,000 for the second quarter of 2009, bioglue revenues would have been $12.7 million. bioglue revenues were $24.1 million for the first six mont...

CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results

...taples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. bioglue Aesthetic (TM) Medical Adhesive is CE marked in the European Community for...

BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates

... market in 1998 and in the United States in 2001. bioglue is a leading surgical adhesive used in cardiovascular surgeries worldwide. "I have been using bioglue since its market introduction almost 10 years ago,...ist Hospital, Indianapolis, Ind. "I have utilized bioglue in over 1,000 patients undergoing a variety of car...

Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology

...n adjunct to sutures and staples in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...taples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Aust...

CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoL...

William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. The Company also distributes the CryoL...
Bioglue in Medical Technology

Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a ...
Bioglue in Medical Products

Bioglue

Features:... The bioglue component has a shelf life of 3 years if stored at 25 C. bioglue also adheres to synthetic graft materials via mechanical interlocks within ...
Company:Cryolife, Inc.
Bioglue in Biological Technology

CryoLife Reports Record First Quarter Revenues of $26.7 Million

...ere was a 2 percent increase in the milliliters of bioglue shipped, revenues decreased 1 percent. Excluding ...exchange rates quarter over quarter, which reduced bioglue revenues by $306,000 in the first quarter of 2009, bioglue revenues would have been $12.1 million, or a 2 per...

CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008

...fourth quarter of 2007, an increase of 5 percent. bioglue revenues were $48.6 million for the year ended Dec...r 31, 2007, an increase of 11 percent. U.S. bioglue revenues were $8.6 million and $8.1 million for th...rth quarters of 2008 and 2007, respectively. U.S. bioglue revenues were $34.4 million and $31.6 million for ...

CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone

...BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH, a...

CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007

... third quarter of 2007, an increase of 13 percent. bioglue revenues were $36.5 million for the first nine mon... months of 2007, an increase of 13 percent. U.S. bioglue revenues were $8.1 million and $7.4 million in the...third quarter of 2008 and 2007, respectively. U.S. bioglue revenues were $25.8 million and $23.4 million in t...

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...

CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.

... BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. bioglue is also CE marked in the European Community and approved in Canada and Australia for use in soft tissue repair. CryoLife distributes Hemostase MPH(R),...
Other Tags
(Date:4/24/2014)... of three survivors of critical illness, according to ... Respiratory Medicine , and the majority of patients ... It is one of the largest studies to ... critical care survivors, according to lead author James ... highlights a significant public health issue, with roughly ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
(Date:4/24/2014)... 2009 the influenza pH1N1 virus caused the first flu ... in May 2009 and killed more than 50 people ... Finns mainly during flu epidemics (winter/spring seasons). , ... serious complicated illnesses. World Health Organization has recommended Tamiflu ... The disadvantage of this drug is that it targets ...
(Date:4/23/2014)... (MGH) investigators may lead to greater availability and acceptability ... use of fecal material from healthy donors to ... ( C. difficile ) bacteria. In their ... Infectious Diseases , the researchers report that use of ... was as successful in curing recurrent C. difficile ...
Breaking Medicine News(10 mins):Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3
(Date:4/24/2014)... the largest river turtle in North America, weighing in ... century. Now researchers from Florida and the University of ... but three. , Examining museum specimens and wild ... ancient reptile. , Once heavily hunted for turtle meat ... Turtle Soup in the 1960s the riverine populations ...
(Date:4/24/2014)... A common plant puts out a welcome mat to bacteria ... mix. , The study published this week in the ... targets during the battle between microbe and host that researchers ... the humble and oft-studied plant Arabidopsis puts out ... It,s as if a hostile army were unknowingly passing by ...
(Date:4/23/2014)... pair of bioethics experts have added "playwright" to their ... in grappling with an onslaught of ethical issues as ... the human genome was first sequenced. , Until ... W. Bush have been performed for, and by, their ... conferences, meetings and in classrooms. With Oxford University ...
Breaking Biology News(10 mins):Two new US turtle species described 2Two new US turtle species described 3How a plant beckons the bacteria that will do it harm 2How a plant beckons the bacteria that will do it harm 3Bioethicists use theatrical narratives to bridge the gap between society and science 2Bioethicists use theatrical narratives to bridge the gap between society and science 3
Other Contents